Cardiovascular Complications of Cancer Therapy: The ... · Risk Factors for Radiation Induced CV...
Transcript of Cardiovascular Complications of Cancer Therapy: The ... · Risk Factors for Radiation Induced CV...
![Page 1: Cardiovascular Complications of Cancer Therapy: The ... · Risk Factors for Radiation Induced CV Disease Total dose >30 Gy or fractioned dose >2Gy/day Heart volume exposed Time since](https://reader034.fdocuments.us/reader034/viewer/2022051914/6004e74baf8e8f776f662779/html5/thumbnails/1.jpg)
Cardiovascular Complications of Cancer Therapy: The Emerging Field of Cardio-Oncology
Michael Fradley, MD Current Perspectives in Oncology Nursing
February 16, 2017
![Page 2: Cardiovascular Complications of Cancer Therapy: The ... · Risk Factors for Radiation Induced CV Disease Total dose >30 Gy or fractioned dose >2Gy/day Heart volume exposed Time since](https://reader034.fdocuments.us/reader034/viewer/2022051914/6004e74baf8e8f776f662779/html5/thumbnails/2.jpg)
Disclosures: Ariad Pharmaceutics – Advisory Board
![Page 3: Cardiovascular Complications of Cancer Therapy: The ... · Risk Factors for Radiation Induced CV Disease Total dose >30 Gy or fractioned dose >2Gy/day Heart volume exposed Time since](https://reader034.fdocuments.us/reader034/viewer/2022051914/6004e74baf8e8f776f662779/html5/thumbnails/3.jpg)
Objectives
Discuss frequently encountered cardiovascular complications in cancer patients and survivors
Highlight cancer therapies with associated cardiotoxicity
Identify novel diagnostic and treatment strategies
for cardiotoxicities
![Page 4: Cardiovascular Complications of Cancer Therapy: The ... · Risk Factors for Radiation Induced CV Disease Total dose >30 Gy or fractioned dose >2Gy/day Heart volume exposed Time since](https://reader034.fdocuments.us/reader034/viewer/2022051914/6004e74baf8e8f776f662779/html5/thumbnails/4.jpg)
Scope Of The Problem
1 of 3 adults have CV disease (82 million) 12 million cancer patients; 12 million cancer survivors
Approximately 30% of patients receiving cancer therapy
will have cardiovascular complications Some complications may not become apparent for 10-20
years after completion of treatments
![Page 5: Cardiovascular Complications of Cancer Therapy: The ... · Risk Factors for Radiation Induced CV Disease Total dose >30 Gy or fractioned dose >2Gy/day Heart volume exposed Time since](https://reader034.fdocuments.us/reader034/viewer/2022051914/6004e74baf8e8f776f662779/html5/thumbnails/5.jpg)
Trends in 5-Year Cancer Survival
www.pancreaticcanceraction.org
![Page 6: Cardiovascular Complications of Cancer Therapy: The ... · Risk Factors for Radiation Induced CV Disease Total dose >30 Gy or fractioned dose >2Gy/day Heart volume exposed Time since](https://reader034.fdocuments.us/reader034/viewer/2022051914/6004e74baf8e8f776f662779/html5/thumbnails/6.jpg)
Progression of CV Complications in Cancer Patients
Hermann and Lerman. Trends Cardiovasc Med. 2014 Oct; 24(7): 285–295.
![Page 7: Cardiovascular Complications of Cancer Therapy: The ... · Risk Factors for Radiation Induced CV Disease Total dose >30 Gy or fractioned dose >2Gy/day Heart volume exposed Time since](https://reader034.fdocuments.us/reader034/viewer/2022051914/6004e74baf8e8f776f662779/html5/thumbnails/7.jpg)
CV Disease: Common after Cancer Treatment
Chun Chao et al. JCO 2016;34:1626-1633
![Page 8: Cardiovascular Complications of Cancer Therapy: The ... · Risk Factors for Radiation Induced CV Disease Total dose >30 Gy or fractioned dose >2Gy/day Heart volume exposed Time since](https://reader034.fdocuments.us/reader034/viewer/2022051914/6004e74baf8e8f776f662779/html5/thumbnails/8.jpg)
CV Disease: Common after Cancer Treatment
Gregory T. Armstrong et al. JCO 2013;31:3673-3680
A. Coronary Artery Disease B. Valve Disease C. Arrhythmias D. Heart Failure
![Page 9: Cardiovascular Complications of Cancer Therapy: The ... · Risk Factors for Radiation Induced CV Disease Total dose >30 Gy or fractioned dose >2Gy/day Heart volume exposed Time since](https://reader034.fdocuments.us/reader034/viewer/2022051914/6004e74baf8e8f776f662779/html5/thumbnails/9.jpg)
Gregory T. Armstrong et al. JCO 2013;31:3673-3680
A. Hypertension B. Dyslipidemia C. Diabetes D. Obesity E. Multiple
Cardiac RF
CV Disease: Common after Cancer Treatment
![Page 10: Cardiovascular Complications of Cancer Therapy: The ... · Risk Factors for Radiation Induced CV Disease Total dose >30 Gy or fractioned dose >2Gy/day Heart volume exposed Time since](https://reader034.fdocuments.us/reader034/viewer/2022051914/6004e74baf8e8f776f662779/html5/thumbnails/10.jpg)
Cardio-Oncology: Definition
Cardio-oncology is a multidisciplinary field aimed at managing cardiovascular risk and preventing cardiovascular disease in cancer patients and survivors. Eliminate cardiac disease as a barrier to
effective cancer therapy
![Page 11: Cardiovascular Complications of Cancer Therapy: The ... · Risk Factors for Radiation Induced CV Disease Total dose >30 Gy or fractioned dose >2Gy/day Heart volume exposed Time since](https://reader034.fdocuments.us/reader034/viewer/2022051914/6004e74baf8e8f776f662779/html5/thumbnails/11.jpg)
Cardio-Oncology – A Collaborative Discipline
![Page 12: Cardiovascular Complications of Cancer Therapy: The ... · Risk Factors for Radiation Induced CV Disease Total dose >30 Gy or fractioned dose >2Gy/day Heart volume exposed Time since](https://reader034.fdocuments.us/reader034/viewer/2022051914/6004e74baf8e8f776f662779/html5/thumbnails/12.jpg)
Cardiomyopathy and Heart Failure
![Page 13: Cardiovascular Complications of Cancer Therapy: The ... · Risk Factors for Radiation Induced CV Disease Total dose >30 Gy or fractioned dose >2Gy/day Heart volume exposed Time since](https://reader034.fdocuments.us/reader034/viewer/2022051914/6004e74baf8e8f776f662779/html5/thumbnails/13.jpg)
Chemotherapy Induced LV Dysfunction
Yeh and Bickford. JACC. 2009; 53: 2231-247. Zamorano et al. Eur Heart J. 2016. Epub ahead of print.
![Page 14: Cardiovascular Complications of Cancer Therapy: The ... · Risk Factors for Radiation Induced CV Disease Total dose >30 Gy or fractioned dose >2Gy/day Heart volume exposed Time since](https://reader034.fdocuments.us/reader034/viewer/2022051914/6004e74baf8e8f776f662779/html5/thumbnails/14.jpg)
Cardiotoxicity – Definitions
Type 1 Cardiotoxicity
Structural and cellular changes (vaculoization, myofibrillar disarray)
Cellular necrosis Irreversible
Type 2 Cardiotoxicity
No structural or cellular changes
Signaling abnormalities lead to cardiac stress
Reversible
Decline in initial EF by more than 10% to less 53% regardless of CHF symptoms
![Page 15: Cardiovascular Complications of Cancer Therapy: The ... · Risk Factors for Radiation Induced CV Disease Total dose >30 Gy or fractioned dose >2Gy/day Heart volume exposed Time since](https://reader034.fdocuments.us/reader034/viewer/2022051914/6004e74baf8e8f776f662779/html5/thumbnails/15.jpg)
Anthracycline Induced Cardiomyopathy
Felker et al. New Engl J Med. 2000; 342; 1077-1084.
![Page 16: Cardiovascular Complications of Cancer Therapy: The ... · Risk Factors for Radiation Induced CV Disease Total dose >30 Gy or fractioned dose >2Gy/day Heart volume exposed Time since](https://reader034.fdocuments.us/reader034/viewer/2022051914/6004e74baf8e8f776f662779/html5/thumbnails/16.jpg)
Anthracycline Induced Cardiomyopathy
Van Hoff et al. American Journal of Medicine. 1977.
![Page 17: Cardiovascular Complications of Cancer Therapy: The ... · Risk Factors for Radiation Induced CV Disease Total dose >30 Gy or fractioned dose >2Gy/day Heart volume exposed Time since](https://reader034.fdocuments.us/reader034/viewer/2022051914/6004e74baf8e8f776f662779/html5/thumbnails/17.jpg)
Anthracycline Induced Cardiomyopathy
Ann Oncol. 2009.
![Page 18: Cardiovascular Complications of Cancer Therapy: The ... · Risk Factors for Radiation Induced CV Disease Total dose >30 Gy or fractioned dose >2Gy/day Heart volume exposed Time since](https://reader034.fdocuments.us/reader034/viewer/2022051914/6004e74baf8e8f776f662779/html5/thumbnails/18.jpg)
Anthracycline Induced Cardiomyopathy: Risk Factors
Cumulative Dose Age Female Gender Concomitant use of additional
chemotherapy or XRT Underlying CV disease
![Page 19: Cardiovascular Complications of Cancer Therapy: The ... · Risk Factors for Radiation Induced CV Disease Total dose >30 Gy or fractioned dose >2Gy/day Heart volume exposed Time since](https://reader034.fdocuments.us/reader034/viewer/2022051914/6004e74baf8e8f776f662779/html5/thumbnails/19.jpg)
LV Dysfunction and Targeted Therapies
HER2+ Targeted Therapies – Trastuzumab (Herceptin) – Pertuzumab (Perjeta)
Sunitinib
![Page 20: Cardiovascular Complications of Cancer Therapy: The ... · Risk Factors for Radiation Induced CV Disease Total dose >30 Gy or fractioned dose >2Gy/day Heart volume exposed Time since](https://reader034.fdocuments.us/reader034/viewer/2022051914/6004e74baf8e8f776f662779/html5/thumbnails/20.jpg)
Trastuzumab and LVEF
Slamon, NEJM, 2011
![Page 21: Cardiovascular Complications of Cancer Therapy: The ... · Risk Factors for Radiation Induced CV Disease Total dose >30 Gy or fractioned dose >2Gy/day Heart volume exposed Time since](https://reader034.fdocuments.us/reader034/viewer/2022051914/6004e74baf8e8f776f662779/html5/thumbnails/21.jpg)
Significant Heart Failure Associated with Trastuzuamab
Ewer and Ewer, Nat. Rev Cardiovasc Med, 2010
![Page 22: Cardiovascular Complications of Cancer Therapy: The ... · Risk Factors for Radiation Induced CV Disease Total dose >30 Gy or fractioned dose >2Gy/day Heart volume exposed Time since](https://reader034.fdocuments.us/reader034/viewer/2022051914/6004e74baf8e8f776f662779/html5/thumbnails/22.jpg)
Mechanism of Trastuzumab Cardiotoxicity
Hansel, Nat Rev Drug Discov, 2010
![Page 23: Cardiovascular Complications of Cancer Therapy: The ... · Risk Factors for Radiation Induced CV Disease Total dose >30 Gy or fractioned dose >2Gy/day Heart volume exposed Time since](https://reader034.fdocuments.us/reader034/viewer/2022051914/6004e74baf8e8f776f662779/html5/thumbnails/23.jpg)
Trastuzumab Cardiac Monitoring Algorithm
Curigliano et al, Ann Oncol, 2012.
![Page 24: Cardiovascular Complications of Cancer Therapy: The ... · Risk Factors for Radiation Induced CV Disease Total dose >30 Gy or fractioned dose >2Gy/day Heart volume exposed Time since](https://reader034.fdocuments.us/reader034/viewer/2022051914/6004e74baf8e8f776f662779/html5/thumbnails/24.jpg)
Trastuzumab Cardiotoxicity Increases Over Time
Bowles et al. J Natl Cancer Inst. 2012; 104: 1293-1305
![Page 25: Cardiovascular Complications of Cancer Therapy: The ... · Risk Factors for Radiation Induced CV Disease Total dose >30 Gy or fractioned dose >2Gy/day Heart volume exposed Time since](https://reader034.fdocuments.us/reader034/viewer/2022051914/6004e74baf8e8f776f662779/html5/thumbnails/25.jpg)
Trastuzumab and Anthracycline Cardiotoxicity: Fibrosis and Apoptosis
Riccio et al. Hum Vaccin Immunother. 2016; 12: 1124-31.
![Page 26: Cardiovascular Complications of Cancer Therapy: The ... · Risk Factors for Radiation Induced CV Disease Total dose >30 Gy or fractioned dose >2Gy/day Heart volume exposed Time since](https://reader034.fdocuments.us/reader034/viewer/2022051914/6004e74baf8e8f776f662779/html5/thumbnails/26.jpg)
TKI Induced LV Dysfunction P
erce
nt w
ith G
rade
2-4
LV
EF
Dec
line
Hall PS et al. JACC Heart Fail. 2013; 1(1): 72-8.
![Page 27: Cardiovascular Complications of Cancer Therapy: The ... · Risk Factors for Radiation Induced CV Disease Total dose >30 Gy or fractioned dose >2Gy/day Heart volume exposed Time since](https://reader034.fdocuments.us/reader034/viewer/2022051914/6004e74baf8e8f776f662779/html5/thumbnails/27.jpg)
Risk of CHF with Sunitinib
Richards et al. JCO 2011;29:3450-3456
![Page 28: Cardiovascular Complications of Cancer Therapy: The ... · Risk Factors for Radiation Induced CV Disease Total dose >30 Gy or fractioned dose >2Gy/day Heart volume exposed Time since](https://reader034.fdocuments.us/reader034/viewer/2022051914/6004e74baf8e8f776f662779/html5/thumbnails/28.jpg)
Carfilzomib Induced Cardiotoxicity
Siegel et al. Haematologica. 2013.
![Page 29: Cardiovascular Complications of Cancer Therapy: The ... · Risk Factors for Radiation Induced CV Disease Total dose >30 Gy or fractioned dose >2Gy/day Heart volume exposed Time since](https://reader034.fdocuments.us/reader034/viewer/2022051914/6004e74baf8e8f776f662779/html5/thumbnails/29.jpg)
Techniques to Improve the Identification of Cardiotoxicity: Beyond Ejection Fraction
Biomarkers Strain Imaging
![Page 30: Cardiovascular Complications of Cancer Therapy: The ... · Risk Factors for Radiation Induced CV Disease Total dose >30 Gy or fractioned dose >2Gy/day Heart volume exposed Time since](https://reader034.fdocuments.us/reader034/viewer/2022051914/6004e74baf8e8f776f662779/html5/thumbnails/30.jpg)
Troponins and Development of Cardiotoxicity
Cardinale, Circ, 2004
![Page 31: Cardiovascular Complications of Cancer Therapy: The ... · Risk Factors for Radiation Induced CV Disease Total dose >30 Gy or fractioned dose >2Gy/day Heart volume exposed Time since](https://reader034.fdocuments.us/reader034/viewer/2022051914/6004e74baf8e8f776f662779/html5/thumbnails/31.jpg)
Strain Imaging to Diagnose Chemotherapy Induced Cardiomyopathy
Measure of myocardial deformation Identification of subclinical LV dysfunction
prior to EF changes Potential role for early cardiovascular
intervention
![Page 32: Cardiovascular Complications of Cancer Therapy: The ... · Risk Factors for Radiation Induced CV Disease Total dose >30 Gy or fractioned dose >2Gy/day Heart volume exposed Time since](https://reader034.fdocuments.us/reader034/viewer/2022051914/6004e74baf8e8f776f662779/html5/thumbnails/32.jpg)
Abnormal Strain and Trastuzumab Exposure
Hare, Am Heart J, 2009.
![Page 33: Cardiovascular Complications of Cancer Therapy: The ... · Risk Factors for Radiation Induced CV Disease Total dose >30 Gy or fractioned dose >2Gy/day Heart volume exposed Time since](https://reader034.fdocuments.us/reader034/viewer/2022051914/6004e74baf8e8f776f662779/html5/thumbnails/33.jpg)
Abnormal Strain and Trastuzumab
Kazuaki Negishi et al. Eur Heart J Cardiovasc Imaging 2013;ehjci.jet159
![Page 34: Cardiovascular Complications of Cancer Therapy: The ... · Risk Factors for Radiation Induced CV Disease Total dose >30 Gy or fractioned dose >2Gy/day Heart volume exposed Time since](https://reader034.fdocuments.us/reader034/viewer/2022051914/6004e74baf8e8f776f662779/html5/thumbnails/34.jpg)
Prevention of Chemotherapy Induced Cardiomyopathy
A B
Cardinale et al. Circ. 2006. Kaya et al. Int J Cardiol. 2012.
![Page 35: Cardiovascular Complications of Cancer Therapy: The ... · Risk Factors for Radiation Induced CV Disease Total dose >30 Gy or fractioned dose >2Gy/day Heart volume exposed Time since](https://reader034.fdocuments.us/reader034/viewer/2022051914/6004e74baf8e8f776f662779/html5/thumbnails/35.jpg)
Prevention of Chemotherapy Induced Cardiomyopathy: PRADA
Gulati et al. Eur Heart J. 2016; 37: 1671-80.
![Page 36: Cardiovascular Complications of Cancer Therapy: The ... · Risk Factors for Radiation Induced CV Disease Total dose >30 Gy or fractioned dose >2Gy/day Heart volume exposed Time since](https://reader034.fdocuments.us/reader034/viewer/2022051914/6004e74baf8e8f776f662779/html5/thumbnails/36.jpg)
Coronary Artery Disease, Myocardial Infarction, and Peripheral Arterial Disease
![Page 37: Cardiovascular Complications of Cancer Therapy: The ... · Risk Factors for Radiation Induced CV Disease Total dose >30 Gy or fractioned dose >2Gy/day Heart volume exposed Time since](https://reader034.fdocuments.us/reader034/viewer/2022051914/6004e74baf8e8f776f662779/html5/thumbnails/37.jpg)
Therapies Associated With Vascular Disease
Radiation Tyrosine Kinase Inhibitors
– Nilotinib – Ponatinib
![Page 38: Cardiovascular Complications of Cancer Therapy: The ... · Risk Factors for Radiation Induced CV Disease Total dose >30 Gy or fractioned dose >2Gy/day Heart volume exposed Time since](https://reader034.fdocuments.us/reader034/viewer/2022051914/6004e74baf8e8f776f662779/html5/thumbnails/38.jpg)
CV Complications of Radiation
Important part of treatment for many cancers including breast, lung and lymphoma
Increased risk with increased dose (Gray) Complications typically seen 5-10 years post exposure Complications include:
– Premature CAD – Carotid Disease – Valvular disease (especially aortic and mitral disease) – Pericardial and myocardial disease – Heart failure – Conduction abnormalities
![Page 39: Cardiovascular Complications of Cancer Therapy: The ... · Risk Factors for Radiation Induced CV Disease Total dose >30 Gy or fractioned dose >2Gy/day Heart volume exposed Time since](https://reader034.fdocuments.us/reader034/viewer/2022051914/6004e74baf8e8f776f662779/html5/thumbnails/39.jpg)
Risk Factors for Radiation Induced CV Disease
Total dose >30 Gy or fractioned dose >2Gy/day
Heart volume exposed Time since exposure Adjunctive chemo/hormone therapy Presence of CV risk factors (diabetes, obesity,
smoking, hypertension, dyslipidemia) Younger age
![Page 40: Cardiovascular Complications of Cancer Therapy: The ... · Risk Factors for Radiation Induced CV Disease Total dose >30 Gy or fractioned dose >2Gy/day Heart volume exposed Time since](https://reader034.fdocuments.us/reader034/viewer/2022051914/6004e74baf8e8f776f662779/html5/thumbnails/40.jpg)
![Page 41: Cardiovascular Complications of Cancer Therapy: The ... · Risk Factors for Radiation Induced CV Disease Total dose >30 Gy or fractioned dose >2Gy/day Heart volume exposed Time since](https://reader034.fdocuments.us/reader034/viewer/2022051914/6004e74baf8e8f776f662779/html5/thumbnails/41.jpg)
Radiation and Carotid Artery Disease
Huang et al., Rad Onc, 2013
Halak et al, Eur J Vasc Enodvasc Surg, 2002
![Page 42: Cardiovascular Complications of Cancer Therapy: The ... · Risk Factors for Radiation Induced CV Disease Total dose >30 Gy or fractioned dose >2Gy/day Heart volume exposed Time since](https://reader034.fdocuments.us/reader034/viewer/2022051914/6004e74baf8e8f776f662779/html5/thumbnails/42.jpg)
CML and Nilotinib: ENESTnd Trial
![Page 43: Cardiovascular Complications of Cancer Therapy: The ... · Risk Factors for Radiation Induced CV Disease Total dose >30 Gy or fractioned dose >2Gy/day Heart volume exposed Time since](https://reader034.fdocuments.us/reader034/viewer/2022051914/6004e74baf8e8f776f662779/html5/thumbnails/43.jpg)
Nilotinib and Cardiovascular Events
No of Patients: 28/279 44/277 7/280
Larson RA, et al. Blood. 2014;124:4541.
![Page 44: Cardiovascular Complications of Cancer Therapy: The ... · Risk Factors for Radiation Induced CV Disease Total dose >30 Gy or fractioned dose >2Gy/day Heart volume exposed Time since](https://reader034.fdocuments.us/reader034/viewer/2022051914/6004e74baf8e8f776f662779/html5/thumbnails/44.jpg)
CML and Ponatinib: Cardiovascular Events
Serious AE % AE % Serous AE % AE %
Cardiovascular 5 6 6 10
Cerebrovascular 2 3 4 7
Peripheral Vascular 2 4 4 7
Venous Thromboembolism 2 3 3 5
Total Vascular Occlusion 11 16 17 29
US Ponatinib Insert (7/23/12) Median Follow up: 12 Mos
(340 pt-years)
PACE Trial (9/3/13) Medial Follow Up: 24 Mos
(578 pt-years)
Cortes JE et al. Blood. 2014;124:3135.
![Page 45: Cardiovascular Complications of Cancer Therapy: The ... · Risk Factors for Radiation Induced CV Disease Total dose >30 Gy or fractioned dose >2Gy/day Heart volume exposed Time since](https://reader034.fdocuments.us/reader034/viewer/2022051914/6004e74baf8e8f776f662779/html5/thumbnails/45.jpg)
5-Fluorouracil Induced Myocardial Ischemia and Infarction
Cheat pain is a common symptom among patients treated with 5-FU
Etiology is thought secondary to vasospasm though myocarditis is also possible
Risk increased with continuous infusions Nitrates of calcium channel blockers may prevent
episodes
![Page 46: Cardiovascular Complications of Cancer Therapy: The ... · Risk Factors for Radiation Induced CV Disease Total dose >30 Gy or fractioned dose >2Gy/day Heart volume exposed Time since](https://reader034.fdocuments.us/reader034/viewer/2022051914/6004e74baf8e8f776f662779/html5/thumbnails/46.jpg)
QT Interval Prolongation and Arrhythmias
![Page 47: Cardiovascular Complications of Cancer Therapy: The ... · Risk Factors for Radiation Induced CV Disease Total dose >30 Gy or fractioned dose >2Gy/day Heart volume exposed Time since](https://reader034.fdocuments.us/reader034/viewer/2022051914/6004e74baf8e8f776f662779/html5/thumbnails/47.jpg)
Malignancy and QT Prolongation
Brell. Prog Cardiovasc Dis. 2010; 53” 164-72.
![Page 48: Cardiovascular Complications of Cancer Therapy: The ... · Risk Factors for Radiation Induced CV Disease Total dose >30 Gy or fractioned dose >2Gy/day Heart volume exposed Time since](https://reader034.fdocuments.us/reader034/viewer/2022051914/6004e74baf8e8f776f662779/html5/thumbnails/48.jpg)
Chemothearpy Associated with QT Prolongation Chemotherapy Agents Incidence (%) Frequency
of Use Small Molecule Tyrosine Kinase Inhibitors • Sunitinib • Vandetinib • Nilotinib • Dasatinib
<1-3 15-18 1-3 <1
++ +
++ ++
Histone Deacetylase Inhibitors • Vorinostat
3.5-6
+
Miscellaneous • Aresenic
26-93
+
![Page 49: Cardiovascular Complications of Cancer Therapy: The ... · Risk Factors for Radiation Induced CV Disease Total dose >30 Gy or fractioned dose >2Gy/day Heart volume exposed Time since](https://reader034.fdocuments.us/reader034/viewer/2022051914/6004e74baf8e8f776f662779/html5/thumbnails/49.jpg)
Chemotherapy and QT Prolongation
Lisa M. Ballou et al. Circulation Research. 2015;116:127-137
![Page 50: Cardiovascular Complications of Cancer Therapy: The ... · Risk Factors for Radiation Induced CV Disease Total dose >30 Gy or fractioned dose >2Gy/day Heart volume exposed Time since](https://reader034.fdocuments.us/reader034/viewer/2022051914/6004e74baf8e8f776f662779/html5/thumbnails/50.jpg)
Cancer and Atrial Fibrillation
O’Neal et al. Am J Cardiol. 2015; 116(12): 1858-62.
![Page 51: Cardiovascular Complications of Cancer Therapy: The ... · Risk Factors for Radiation Induced CV Disease Total dose >30 Gy or fractioned dose >2Gy/day Heart volume exposed Time since](https://reader034.fdocuments.us/reader034/viewer/2022051914/6004e74baf8e8f776f662779/html5/thumbnails/51.jpg)
Chemotherapy and the Risk of Atrial Fibrillation
Adapted from Guglin et al. Europace. 2009; 11: 1579-1586. Adapted from McMullen et al. Blood. 2014; 124: 3829-3830
![Page 52: Cardiovascular Complications of Cancer Therapy: The ... · Risk Factors for Radiation Induced CV Disease Total dose >30 Gy or fractioned dose >2Gy/day Heart volume exposed Time since](https://reader034.fdocuments.us/reader034/viewer/2022051914/6004e74baf8e8f776f662779/html5/thumbnails/52.jpg)
Hypertension
![Page 53: Cardiovascular Complications of Cancer Therapy: The ... · Risk Factors for Radiation Induced CV Disease Total dose >30 Gy or fractioned dose >2Gy/day Heart volume exposed Time since](https://reader034.fdocuments.us/reader034/viewer/2022051914/6004e74baf8e8f776f662779/html5/thumbnails/53.jpg)
VEGF Inhibitors and Hypertension P
erce
nt D
evel
opin
g G
rade
2-4
H
yper
tens
ion
Hall PS et al. JACC Heart Fail. 2013; 1(1): 72-8.
![Page 54: Cardiovascular Complications of Cancer Therapy: The ... · Risk Factors for Radiation Induced CV Disease Total dose >30 Gy or fractioned dose >2Gy/day Heart volume exposed Time since](https://reader034.fdocuments.us/reader034/viewer/2022051914/6004e74baf8e8f776f662779/html5/thumbnails/54.jpg)
Mechanism of VEGF Induced Hypertension
http://omicsonline.org/JGSGTimages/2157-7412-2-105-g001.html
![Page 55: Cardiovascular Complications of Cancer Therapy: The ... · Risk Factors for Radiation Induced CV Disease Total dose >30 Gy or fractioned dose >2Gy/day Heart volume exposed Time since](https://reader034.fdocuments.us/reader034/viewer/2022051914/6004e74baf8e8f776f662779/html5/thumbnails/55.jpg)
VEGF Inhibitors and Hypertension: Marker of Efficacy?
Rini et al. JNCI J Natl Cancer Inst. 2011;103:763-773
![Page 56: Cardiovascular Complications of Cancer Therapy: The ... · Risk Factors for Radiation Induced CV Disease Total dose >30 Gy or fractioned dose >2Gy/day Heart volume exposed Time since](https://reader034.fdocuments.us/reader034/viewer/2022051914/6004e74baf8e8f776f662779/html5/thumbnails/56.jpg)
VEGF Inhibitor Induced Hypertension: Treatment Options
First Line Therapies – ACE Inhibitors/Angiotensin
Receptor Blockers – Dihydropyridine Calcium Channel
Blockers (CCBs)
Second Line Therapies – Beta blockers and Diuretics
Novel/Investigational Therapies – Nitric Oxide Donating
Medications – Endothelin-1 Receptor
Antagonists
Kaplan-Meier Estimate of Overall Survival Stratified by Antihypertensive Use
McKay et al. Clin Cancer Res 2015;21:2471-2479
![Page 57: Cardiovascular Complications of Cancer Therapy: The ... · Risk Factors for Radiation Induced CV Disease Total dose >30 Gy or fractioned dose >2Gy/day Heart volume exposed Time since](https://reader034.fdocuments.us/reader034/viewer/2022051914/6004e74baf8e8f776f662779/html5/thumbnails/57.jpg)
Valvular Heart Disease
![Page 58: Cardiovascular Complications of Cancer Therapy: The ... · Risk Factors for Radiation Induced CV Disease Total dose >30 Gy or fractioned dose >2Gy/day Heart volume exposed Time since](https://reader034.fdocuments.us/reader034/viewer/2022051914/6004e74baf8e8f776f662779/html5/thumbnails/58.jpg)
Valvular Heart Disease: Etiology and Risk Factors
Most often associated with chest radiation May also be associated with anthracycline
exposure Aortic and mitral valves most commonly
affected Regurgitant lesions more common than
stenotic Presents 10+ years post treatments
![Page 59: Cardiovascular Complications of Cancer Therapy: The ... · Risk Factors for Radiation Induced CV Disease Total dose >30 Gy or fractioned dose >2Gy/day Heart volume exposed Time since](https://reader034.fdocuments.us/reader034/viewer/2022051914/6004e74baf8e8f776f662779/html5/thumbnails/59.jpg)
Prevalence of Valvular Abnormalities in Hodgkin Lymphoma Survivors
Bijl et al. Am J Cardiol. 2016; 117:691-6.
![Page 60: Cardiovascular Complications of Cancer Therapy: The ... · Risk Factors for Radiation Induced CV Disease Total dose >30 Gy or fractioned dose >2Gy/day Heart volume exposed Time since](https://reader034.fdocuments.us/reader034/viewer/2022051914/6004e74baf8e8f776f662779/html5/thumbnails/60.jpg)
Monitoring and Prevention of Cardiovascular Disease in Cancer
Patients and Survivors
![Page 61: Cardiovascular Complications of Cancer Therapy: The ... · Risk Factors for Radiation Induced CV Disease Total dose >30 Gy or fractioned dose >2Gy/day Heart volume exposed Time since](https://reader034.fdocuments.us/reader034/viewer/2022051914/6004e74baf8e8f776f662779/html5/thumbnails/61.jpg)
Prevention of Cardiovascular Disease in Cancer Patients: Learn your ABCs
A: Awareness of potential CV dysfunction; aspirin; Ankle-brachial index
B: Blood pressure control C: Cholesterol control; cigarette avoidance D: Diabetes control; healthy dieatary choices E: Exercise. Echo. EKG.
![Page 62: Cardiovascular Complications of Cancer Therapy: The ... · Risk Factors for Radiation Induced CV Disease Total dose >30 Gy or fractioned dose >2Gy/day Heart volume exposed Time since](https://reader034.fdocuments.us/reader034/viewer/2022051914/6004e74baf8e8f776f662779/html5/thumbnails/62.jpg)
Conclusions Cardiovascular toxicity has significant impact on both
cancer patients and survivors LV dysfunction, arrhythmias, ischemia, hypertension and
valvular dysfunction are commonly observed toxicities Radiation therapy has significant impact on the CV
system
Biomarkers and strain imaging may help with the early diagnosis of cardiotoxicity
![Page 63: Cardiovascular Complications of Cancer Therapy: The ... · Risk Factors for Radiation Induced CV Disease Total dose >30 Gy or fractioned dose >2Gy/day Heart volume exposed Time since](https://reader034.fdocuments.us/reader034/viewer/2022051914/6004e74baf8e8f776f662779/html5/thumbnails/63.jpg)
Thank You